Loading patent…
AssigneePulmatrix, Inc.
InventorsRobert W. Clarke, Richard Batycky, Wesley H. Dehaan, David L. Hava, Michael M. Lipp, John Hanrahan
Estimating the term…
The invention relates to methods for treating bacterial infection of the respiratory tract, including pneumonias, such as ventilator-associated pneumonia, and to methods for treating ventilator-associated tracheobronchitis, comprising administering an effective amount of a salt formulation as an aerosol to the respiratory tract of an individual in need thereof. The formulations can also be used to reduce transmission of pathogen which can infect the respiratory tract, cause pneumonia or cause ventilator-associated tracheobronchitis.
A method for treating pneumonia, comprising administering to an individual having pneumonia an effective amount of a calcium salt formulation, wherein said calcium salt formulation is administered as an aerosol to the lungs of said individual.
A method for reducing transmission of pathogen which causes pneumonia, comprising administering to an individual having pneumonia, exhibiting pneumonia-like symptoms or at risk for contracting pneumonia, an effective amount of a calcium salt formulation, wherein said calcium salt formulation is administered as an aerosol to the lung of said individual.
14-17. (canceled)
A method of preventing pneumonia, comprising administering to an individual at risk for contracting pneumonia an effective amount of a calcium salt formulation, wherein said calcium salt formulation is administered as an aerosol to the lung of said individual.
19-21. (canceled)
23-41. (canceled)
A method for prophylaxis of ventilator-associated tracheobronchitis (VAT), comprising administering to an individual at risk for VAT an effective amount of a calcium salt formulation, wherein said calcium salt formulation is administered as an aerosol to the lung of said individual.
43-49. (canceled)
Dependencies are inferred from the claim text.